Skip to main content
OpenTrials

Clinical trial condition

Hematopoietic and Lymphoid Cell Neoplasm

Explore clinical trials studying Hematopoietic and Lymphoid Cell Neoplasm. Study availability and eligibility vary by location and protocol.

160 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hematopoietic and Lymphoid Cell Neoplasm trial results

Completed

INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant

NCT01602211

Conditions
Behavior, Behavioral Symptoms, Bone Marrow Diseases, +10 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
View Trial Details
Completed

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

NCT01251575

Conditions
Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, +67 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00075478

Conditions
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
Locations
  • OHSU Cancer Institute-Southern Region Medford, Oregon, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
  • VA Puget Sound Health Care System Seattle, Washington, United States
View Trial Details
Terminated

Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis

NCT04438382

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +5 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Bronson Battle Creek Battle Creek, Michigan, United States
  • Mercy Health Saint Mary's Grand Rapids, Michigan, United States
View all 18 locations
View Trial Details

Related conditions